Takeshi Sumida

Mergers & Acquisitions and Strategic Joint Ventures

• Represented life sciences client in $518-million acquisition of therapeutic technology company.
• Represented equity firm in sale of healthcare pricing company to leading industry competitor.
• Represented a U.S.-based biopharma company in its $1.9-billion sale to a Belgian-based biopharma multinational.
• Represented a public company based in Japan in its $1.6-billion acquisition of an automotive interiors company.
• Represented an Australian public company in the establishment of a joint venture with a Japanese company.

Financing

• Represented an international gaming company in its investment in Series B round financing of a Japanese gaming company.
• Represented a Japanese robotics startup in its Series B round financing and bridge financing.

Other Transactions

• Represented an international bank in connection with its solar project financing projects in Japan.
• Represented a U.S. data center operator in its proposed conversion to a real estate investment trust.